Cancer genome analysis has demonstrated that some breast and ovarian tumours show reduced homologous recombination, a feature that can be therapeutically exploited. Here, Alexandrov et al.search for this mutational signature in 36 different cancer types and find that some gastric tumours also harbour this mutational spectrum.
- Ludmil B. Alexandrov
- Serena Nik-Zainal
- Michael R Stratton